Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Strategic Overhaul | Explore Clarivate's ambitious Value Creation Plan, aimed at optimizing its business model and portfolio to address current market challenges and position for future growth |
Revenue Transition | Delve into Clarivate's shift from transactional to subscription-based revenue models, a move that promises long-term stability but poses short-term risks |
Segment Performance | Uncover the nuanced performance across Clarivate's key business segments, including Intellectual Property, Life Sciences & Healthcare, and Academic & Government |
Market Outlook | Analyst targets for Clarivate range from $4 to $8 per share, reflecting mixed opinions on the company's prospects amid leadership changes and strategic shifts |
Metrics to compare | CLVT | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipCLVTPeersSector | |
---|---|---|---|---|
P/E Ratio | −4.3x | 6.0x | 12.5x | |
PEG Ratio | −0.11 | 0.18 | 0.03 | |
Price/Book | 0.6x | 2.0x | 1.4x | |
Price / LTM Sales | 1.2x | 0.9x | 1.2x | |
Upside (Analyst Target) | 14.2% | 8.5% | 14.4% | |
Fair Value Upside | Unlock | 19.7% | 6.7% | Unlock |